🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/02/2019 | 75,07 | 75,65 | 73,74 | 75,60 | +0,82% | 2,54% | 524.502 |
| 01/02/2019 | 74,17 | 75,41 | 72,57 | 74,99 | +1,79% | 3,84% | 982.318 |
| 31/01/2019 | 73,33 | 74,50 | 73,11 | 73,67 | +0,41% | 1,90% | 625.651 |
| 30/01/2019 | 72,44 | 73,71 | 71,90 | 73,37 | +1,43% | 2,51% | 568.744 |
| 29/01/2019 | 71,64 | 72,68 | 71,22 | 72,34 | +1,62% | 2,04% | 585.095 |
| 28/01/2019 | 71,21 | 71,36 | 69,61 | 71,19 | -0,64% | 2,46% | 745.876 |
| 25/01/2019 | 70,56 | 71,79 | 70,06 | 71,64 | +1,58% | 2,45% | 860.651 |
| 24/01/2019 | 69,87 | 71,58 | 69,56 | 70,52 | +1,14% | 2,90% | 659.474 |
| 23/01/2019 | 70,93 | 72,56 | 69,25 | 69,73 | -1,00% | 4,67% | 931.984 |
| 22/01/2019 | 72,81 | 73,83 | 70,06 | 70,44 | -4,23% | 5,17% | 1.196.159 |
| 18/01/2019 | 69,53 | 75,27 | 68,57 | 73,55 | +6,48% | 9,64% | 2.072.038 |
| 17/01/2019 | 68,81 | 72,02 | 66,23 | 69,07 | +0,61% | 8,42% | 3.497.746 |
| 16/01/2019 | 81,41 | 81,72 | 61,48 | 68,65 | -16,48% | 24,86% | 13.747.168 |
| 15/01/2019 | 79,92 | 82,81 | 79,35 | 82,20 | +2,65% | 4,32% | 920.282 |
| 14/01/2019 | 83,41 | 83,41 | 79,08 | 80,08 | -4,69% | 5,19% | 1.594.344 |
| 11/01/2019 | 84,62 | 85,70 | 82,88 | 84,02 | -0,94% | 3,34% | 659.474 |
| 10/01/2019 | 87,90 | 87,90 | 80,76 | 84,82 | -4,25% | 8,13% | 1.450.394 |
| 09/01/2019 | 87,92 | 90,42 | 87,34 | 88,59 | +1,18% | 3,51% | 818.011 |
| 08/01/2019 | 89,66 | 90,27 | 87,04 | 87,55 | -1,49% | 3,60% | 657.390 |
| 07/01/2019 | 86,47 | 89,17 | 85,80 | 88,88 | +3,43% | 3,90% | 848.949 |
| 04/01/2019 | 84,18 | 87,80 | 84,18 | 85,93 | +3,85% | 4,30% | 652.581 |
| 03/01/2019 | 85,73 | 86,21 | 82,65 | 82,74 | -3,18% | 4,15% | 675.985 |
| 02/01/2019 | 83,34 | 86,12 | 82,88 | 85,46 | +0,96% | 3,89% | 616.033 |
| 31/12/2018 | 85,02 | 86,71 | 83,79 | 84,65 | -0,10% | 3,44% | 747.479 |
| 28/12/2018 | 85,59 | 87,34 | 84,22 | 84,74 | -0,77% | 3,64% | 606.094 |
| 27/12/2018 | 84,72 | 86,86 | 81,94 | 85,40 | -0,70% | 5,81% | 749.723 |
| 26/12/2018 | 80,29 | 86,26 | 80,29 | 86,00 | +7,40% | 7,44% | 751.807 |
| 24/12/2018 | 82,43 | 84,60 | 79,98 | 80,07 | -3,12% | 5,61% | 378.148 |
| 21/12/2018 | 85,06 | 86,58 | 82,38 | 82,66 | -2,54% | 4,94% | 1.897.151 |
| 20/12/2018 | 82,72 | 86,53 | 82,72 | 84,81 | +2,38% | 4,60% | 1.315.422 |